Ocean Biomedical, Inc. (OCEA) Income Statement
OCEA 2024 at a glance
Fiscal year ended December 31, 2024 · U.S. dollarsOCEA revenue and net income
OCEA growth rates
to 2024| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
OCEA quarterly EPS vs estimates
Ocean Biomedical beat the analyst EPS estimate in 1 of the last 4 quarters.
OCEA income statement
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & development | $26,000 | $709,000 | $8.4M | $33.9M | $49,000 | $35,000 |
| Sales, general & admin | $3.8M | $9.5M | $7.7M | $28.4M | $1.6M | $197,000 |
| Total operating expenses | $3.8M | $10.2M | $2.5M | $62.3M | $1.7M | $232,000 |
| Operating income | −$3.8M | −$10.2M | −$2.5M | −$62.3M | −$1.7M | −$232,000 |
| Interest income | — | — | $1.5M | — | — | — |
| Interest expense | $2.0M | $1.8M | $691 | $1,000 | — | — |
| Income before taxes | −$3.3M | −$114.5M | −$958,430 | −$62.3M | −$1.7M | −$232,000 |
| Income taxes | — | — | −$1.5M | −$1,000 | $1,000 | −$171,860 |
| Net income | −$3.3M | −$114.5M | $565,470 | −$62.3M | −$1.7M | −$232,000 |
| EBITDA | −$7.4M | −$112.7M | −$957,739 | −$62.3M | −$1.7M | −$232,000 |
| EPS (diluted) | −$1.34 | −$1.70 | −$0.07 | −$0.04 | −$0.08 | — |
| Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 | Sep '22 | Jun '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & development | $18,000 | $0 | $0 | $0 | $26,000 | $17,000 | $305,000 | $28,000 | $393,000 | $161,000 | $1.9M | $3.2M |
| Sales, general & admin | $940,000 | $1.8M | $768,000 | $682,000 | $569,000 | $643,000 | $2.4M | $2.7M | $4.8M | — | $1.3M | $3.7M |
| Total operating expenses | $958,000 | $1.8M | $768,000 | $682,000 | $595,000 | −$660,000 | $2.7M | $2.7M | $5.2M | $614,178 | $1.4M | $6.9M |
| Operating income | −$958,000 | −$1.8M | −$768,000 | −$682,000 | −$595,000 | $660,000 | −$2.7M | −$2.7M | −$5.2M | −$614,180 | −$1.4M | −$6.9M |
| Interest expense | $343,000 | $433,000 | $461,000 | $515,000 | $637,000 | $500,000 | $293,000 | $668,000 | $301,000 | $624,291 | $61,000 | $433,000 |
| Income before taxes | −$8.2M | $283,000 | −$5.5M | −$17.2M | $13.0M | −$16.9M | −$14.1M | −$13.0M | −$67.4M | $410,050 | −$1.0M | −$7.3M |
| Income taxes | −$3.3M | — | — | — | — | — | $39,586 | $668,000 | $60.6M | −$54,880 | −$27,081 | $433,000 |
| Net income | −$8.2M | $283,000 | −$5.5M | −$17.2M | $13.0M | −$16.9M | −$14.1M | −$13.0M | −$128.0M | $410,050 | −$1.0M | −$7.8M |
| EBITDA | −$7.9M | $716,000 | −$5.1M | −$16.7M | $13.6M | −$16.4M | −$13.8M | −$10.8M | −$71.8M | $15.3M | −$3.6M | −$7.3M |
| EPS (diluted) | $0.01 | $0.01 | −$0.20 | −$0.63 | −$0.52 | −$0.49 | −$0.53 | −$0.41 | −$0.27 | $0.03 | −$0.08 | −$0.01 |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in OCEA's financial statements (latest annual report filed April 8, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
OCEA financial results
Ocean Biomedical reported no revenue in fiscal year 2024 (ended December 31, 2024). It had a net loss of $3.3 million. Diluted earnings per share came to −$1.34.
See the OCEA stock overview for the latest quote and news, or the OCEA chart for price history and technical indicators.
OCEA income statement FAQ
Does Ocean Biomedical have revenue?
Ocean Biomedical reported no revenue for fiscal year 2024, which ended on December 31, 2024.
Is Ocean Biomedical profitable?
No. Ocean Biomedical reported a net loss of $3.3 million in fiscal 2024.
How much does Ocean Biomedical spend on research and development?
Ocean Biomedical spent $0.0 million on research and development in fiscal 2024.
What are Ocean Biomedical's earnings per share?
Ocean Biomedical earned $-1.34 per diluted share in fiscal 2024, compared with $-1.70 a year earlier.
When does Ocean Biomedical's fiscal year end?
Ocean Biomedical's fiscal year ends in December. The latest annual report covers the year ended December 31, 2024 and was filed on April 8, 2025.